MNKD
MANNKIND CORP
NASDAQ · Healthcare · Biotechnology · US
$3.09
+1.64%Forward multiples
Based on analyst estimates
- P/E forward
- 107.48x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 56.09x
- P/S forward
- 1.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -14.79x
- Price / sales
- 2.52x
- Price / cash flow
- -117.07x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 3.08x
- EV / EBITDA
- 40.26x
- EV / EBIT
- 156.47x
- Market cap
- $993.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026